Profound on-treatment viral suppression with peginterferon alfa-2a (40KD) (PEGASYS (R)) plus lamivudine combination therapy limits the development of YMDD mutations, but does not improve sustained response rates over peginterferon alfa-2a (40KD) alone

Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/29471

Title:	Profound on-treatment viral suppression with peginterferon alfa-2a (40KD) (PEGASYS (R)) plus lamivudine combination therapy limits the development of YMDD mutations, but does not improve sustained response rates over peginterferon alfa-2a (40KD) alone
Authors:	Germanidis, G. Marcellin, P. Lau, G. Bonino, F. Farci, P. Hadziyannis, S. Jin, R. Yao, G.B. Piratvisuth, T. Yurdaydın, C. Diago, M. Lai, M.Y. Popescu, M. Pluck, N. Uludağ Üniversitesi/Tıp Fakültesi. Gürel, S.
Keywords:	Gastroenterology and hepatology
Issue Date:	Oct-2004
Publisher:	Wiley
Citation:	Germanidis, G. vd. (2004). “Profound on-treatment viral suppression with peginterferon alfa-2a (40KD) (PEGASYS (R)) plus lamivudine combination therapy limits the development of YMDD mutations, but does not improve sustained response rates over peginterferon alfa-2a (40KD) alone”. Hepatology, 40(4), Supplement 1, 653A-653A.
Description:	Bu çalışma, 29 Ekim-02 Kasım 2004 tarihleri arasında Boston[Amerika Birleşik Devletleri]’da düzenlenen 55. Annual Meeting of the American- Association for the Study of Liver Diseases (AASLD)’de bildiri olarak sunulmuştur.
URI:	http://hdl.handle.net/11452/29471
ISSN:	0270-9139
Appears in Collections:	Web of Science

Files in This Item:

There are no files associated with this item.

DSpace JSPUI